Abbott LaboratoriesABTNYSE
LOADING
|||
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$13.40B
↑ 168% above average
Average (9y)
$5.00B
Historical baseline
Range
High:$13.40B
Low:$477.00M
CAGR
+13.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $13.40B | +134.2% |
| 2023 | $5.72B | -17.5% |
| 2022 | $6.93B | -2.0% |
| 2021 | $7.07B | +57.3% |
| 2020 | $4.50B | +21.9% |
| 2019 | $3.69B | +55.7% |
| 2018 | $2.37B | +396.4% |
| 2017 | $477.00M | -65.9% |
| 2016 | $1.40B | -68.3% |
| 2015 | $4.42B | - |